Cidara Therapeutics INC
UEI FKP3JZ9RUNY9 · CA · SAM.gov record ↗
$58.1M
FY2025 obligations
1
Contract awards
Sep 29, 2025
First action
Jun 1, 2026
Latest action
Obligations by agency
- Department Of Health And Human Services$58.1M
Obligations by NAICS
Monthly obligations
Sep 25
Jun 26
Contracts ending within 18 months (recompete watch)
- 75A50125C00017 ↗$58.1M
DEVELOPMENT OF CD388 AS A LONG-LASTING PROPHYLACTIC ANTI-VIRAL OPTION FOR PROTECTION AGAINST THE HEALTH IMPACTS CAUSED BY INFLUENZA
- Ends
- Sep 28, 2027
- Started
- Sep 29, 2025
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541714
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75A50125C00017 ↗ | DEVELOPMENT OF CD388 AS A LONG-LASTING PROPHYLACTIC ANTI-VIRAL OPTION FOR PROTECTION AGAINST THE HEALTH IMPACTS CAUSED BY INFLUENZA | Office Of Assistant Secretary For Preparedness And Response | 541714 | $58.1M | Sep 29, 2025 | Sep 28, 2027 |
Largest awards
- 75A50125C00017 ↗$58.1M
DEVELOPMENT OF CD388 AS A LONG-LASTING PROPHYLACTIC ANTI-VIRAL OPTION FOR PROTECTION AGAINST THE HEALTH IMPACTS CAUSED BY INFLUENZA
- Ends
- Sep 28, 2027
- Started
- Sep 29, 2025
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541714
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75A50125C00017 ↗ | DEVELOPMENT OF CD388 AS A LONG-LASTING PROPHYLACTIC ANTI-VIRAL OPTION FOR PROTECTION AGAINST THE HEALTH IMPACTS CAUSED BY INFLUENZA | Office Of Assistant Secretary For Preparedness And Response | 541714 | $58.1M | Sep 29, 2025 | Sep 28, 2027 |